GILEAD SCIENCES, INC.
GILD
24 insider filings · Latest: Jun 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2 10:04 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 15,000 | $131.46 | $2.0M | 617,567(D) | View → |
| May 15, 2026 | May 18 9:50 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $132.27 | $396.8K | 173,191(D) | View → |
| May 15, 2026 | May 18 9:45 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 28,000 | $131.29 | $3.7M | 125,779(D) | View → |
| Mar 16, 2026 | Mar 17 10:56 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 3,000 | $144.23 | $432.7K | 131,779(D) | View → |
| Mar 16, 2026 | Mar 17 10:14 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $144.23 | $432.7K | 179,191(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:37 PM | Erin BurkhartSVP, Controllership | Grant/Award | 7,810 | $148.56 | 5,455(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Grant/Award | 155,570 | $148.56 | 122,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 20,026 | — | 68,044(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Grant/Award | 39,890 | $148.56 | 31,475(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Option Exercise | 2,133 | — | 39,046(D) | View → |
← Previous
Page 2 of 2